Most patients with hepatocellular carcinoma (HCC) have liver cirrhosis, which develops
following long periods of chronic liver disease. Cirrhosis is characterized by a decrease in …

Hepatocellular carcinoma (HCC) is a complex condition associated with a poor prognosis.
Treatment outcomes are affected by multiple variables, including liver function, performance …

Search for new substances with antiproliferative activity and apoptosis inducing potential
towards HepG2 cells is important since HCC is notoriously resistant to conventional …

The precise location of tumor and completeness of surgical resection are critical to
successful tumor surgery; thus, the method capable of preoperatively locating a tumor site …

Purpose: To evaluate the value of serum midkine (MDK) as a diagnostic biomarker in
hepatocellular carcinoma, particularly for those with negative alpha-fetoprotein (AFP) and at …

BACKGROUND Significant controversy exists as to which treatment modality is most
effective for small, solitary hepatocellular carcinomas (HCCs): radiofrequency ablation …

Abstract Background/Aims Sphingosine kinase 1 (SphK1), which phosphorylates
sphingosine to sphingosine‐1‐phosphate (S1P), is overexpressed in various types of …

Hepatocellular carcinoma (HCC) is the seventh most common malignancy worldwide. HCC
meets all the criteria established by the World Health Organization for performing …

AIM: To demonstrate that administering heparanase inhibitor PI-88 at 160 mg/d is safe and
promising in reducing hepatocellular carcinoma (HCC) recurrence for up to 3 year following …

AIM: To compare survival and recurrence in hepatocellular carcinoma (HCC) patients who
did or did not receive adjuvant transarterial chemoembolization (TACE). METHODS: A …